Keling hatte uns erfolgreich nach Produkten auf 25 Oct.2017 gegen PO NO.M170807 zur Verfügung gestellt; Ihre gelieferten Luftfilter haben zufrieden stellend seit Installation gearbeitet. Wir sind mit ihren Produkten zufrieden.
—— SIMPOR PHARMA
Da wir coopertae mit ihnen tun, bieten sie immer gute Qualität an und halten die Lieferung rechtzeitig zu uns, wir tun appreicated für ihre nette Unterstützung!
—— Nasir
Dieses ist, zu bestätigen, dass wir u-Art Luftduschtunnel, Luft-Dusche und HEPA-Filter kauften, Sekundärluftfilter, perfilter für unser Projekt von KeLing Purification Technology Co. Ltd, Handels-Quadrat 3C01 Tian Feng, mittleres Gebäude, Nr. 133, Baiyun Handels, Baiyun Disctrict, Guangzhou, Guangdong, China gegen den keinen Vertrag: 2014/4119005942 herein am 22. Oktober, 201
—— IATEC, Argentinien
Produkt kam schneller an, als erwartet und sie etwas sendeten, das speziell ist zusätzlich zu, was ich bestellte. Nette Leute und schneller Service!
—— Mohamed Saad
Ich bin online Chat Jetzt
Firma Neuigkeiten
The Global Market for Modular Cleanrooms: A 2026 Forecast
Market Size & Growth Projections
2025 Baseline: The global modular cleanroom market is estimated to reach $1.8–2.1 billion by the end of 2025, driven by expanding demand in pharmaceuticals, electronics, and biotech.
2026 Forecast: Market size is projected to grow to $2.1–2.5 billion in 2026, representing a 15–20% year-over-year growth rate.
Long-Term Trajectory: Through 2030, the market is expected to maintain a CAGR of 12–15%, reaching $4.5–5.2 billion by the end of the decade. This growth is fueled by regulatory tightening, biopharma expansion, and semiconductor manufacturing investments.
Regional Breakdown
North America: Dominates the market with a 35–40% share in 2026, driven by robust biotech and semiconductor sectors. The U.S. accounts for over 80% of regional demand, supported by FDA regulations and investments in advanced manufacturing.
Asia-Pacific: The fastest-growing region, with a CAGR of 18–20% in 2026. China, India, and South Korea lead growth, driven by:
Expanding generic drug production in India
Semiconductor manufacturing hubs in China and South Korea
Rising healthcare infrastructure investments across Southeast Asia
Europe: Holds a 25–30% share, with Germany and the UK as key markets. Growth is tied to pharmaceutical R&D and medical device manufacturing, aligned with EU GMP regulations.
Key Application Segments
Pharmaceuticals & Biotech: The largest segment (40–45% of market share in 2026), driven by demand for sterile manufacturing environments for vaccines, cell therapies, and biologics.
Electronics & Semiconductors: Accounts for 25–30% of demand, fueled by miniaturization of components requiring ISO Class 5–7 cleanrooms.
Medical Devices: Grows at a 16–18% CAGR in 2026, as regulatory standards tighten for implantable devices and diagnostic equipment.
Aerospace & Defense: Emerging segment with 10–12% growth, driven by precision manufacturing of satellite components and defense electronics.